ID

22640

Beschrijving

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Trefwoorden

Versies (1)
  1. 08-06-17 08-06-17 -
Houder van rechten

Genentech, Inc.

Geüploaded op

8 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

SUBJECT ELIGIBILITY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

Engels

SUBJECT ELIGIBILITY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

1 Formulieren  
Patient administration
Beschrijving

Patient administration

Subject Number
Beschrijving

PT

Datatype

integer

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Beschrijving

PTINIT

Datatype

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Report Date:
Beschrijving

VDT

Datatype

date

Alias
UMLS CUI [1,1]
C1302584
SUBJECT ELIGIBILITY
Beschrijving

SUBJECT ELIGIBILITY

Date Subject Signed Protocol Informed Consent:
Beschrijving

INFORM_CONSENT_DT

Datatype

date

Alias
UMLS CUI [1]
C2985782
Did subject meet all eligibility criteria?
Beschrijving

If No: • Indicate the line number(s) (from worksheet) of eligibility criteria that was not met • Provide details of the deviation from the specified eligibility criteria • Indicate if waiver was given and the date granted

Datatype

integer

Alias
UMLS CUI [1]
C1302261
Eligibility Criteria Not Met
Beschrijving

Eligibility Criteria Not Met

Line Number(s) of Eligibility Criteria Not Met (e.g., E-3)
Beschrijving

CRIT_NOTMET

Datatype

text

Alias
UMLS CUI [1,1]
C1516637
Details
Beschrijving

DEVIATION_DETAILS

Datatype

text

Alias
UMLS CUI [1,1]
C1555471
UMLS CUI [1,2]
C0566251
Was A Waiver Granted?
Beschrijving

APPROVAL

Datatype

boolean

Alias
UMLS CUI [1,1]
C1707901
If Yes, Date:
Beschrijving

APPROVAL_DT

Datatype

date

Alias
UMLS CUI [1,1]
C1707901
UMLS CUI [1,2]
C0011008
Terug naar het begin van de pagina

Similar models

SUBJECT ELIGIBILITY (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Patient administration
PT
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
PTINIT
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
VDT
Item
Report Date:
date
C1302584 (UMLS CUI [1,1])
Item Group
SUBJECT ELIGIBILITY
INFORM_CONSENT_DT
Item
Date Subject Signed Protocol Informed Consent:
date
C2985782 (UMLS CUI [1])
Item
Did subject meet all eligibility criteria?
integer
C1302261 (UMLS CUI [1])
HAND_MOVEMENT_DESC [HDMVTD]
Code List
Did subject meet all eligibility criteria?
CL Item
With Direction (1)
CL Item
Without Direction (2)
Item Group
Eligibility Criteria Not Met
CRIT_NOTMET
Item
Line Number(s) of Eligibility Criteria Not Met (e.g., E-3)
text
C1516637 (UMLS CUI [1,1])
DEVIATION_DETAILS
Item
Details
text
C1555471 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
APPROVAL
Item
Was A Waiver Granted?
boolean
C1707901 (UMLS CUI [1,1])
APPROVAL_DT
Item
If Yes, Date:
date
C1707901 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial